Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Excimer laser seizure

This article was originally published in The Gray Sheet

Executive Summary

Photon Data, Inc. agrees to condemnation of 10 unapproved ophthalmic excimer lasers and related components valued at $13 mil. under a consent decree with FDA, the agency states in a Nov. 16 release. The Winter Park, Florida firm also will recondition various laser components under FDA supervision. FDA had seized the lasers, which were marketed without approval and used for myopia and astigmatism correction procedures, in 1997. Two similar lasers continue to be operated by physicians under investigational device exemptions that do not involve PDI. The company has agreed not to wrongly distribute or falsely indicate lasers in the future, and has agreed to place $100,000 in escrow to pay potential fines of $25,000 for each future violation
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT010971

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel